Athleticode is a technology company on the forefront of providing products and services to physicians and certified athletic trainers who are helping athletes of all ages return to sport competition after suffering a concussion.
Concussion in Sports
Concussions are also known as dingers, bell ringers and a myriad of other terms that have minimized the seriousness of what can be a catastrophic injury. A concussion is generally the result of a sudden, violent blow or jolt to the head. The brain is launched into a collision course with the inside of the skull, resulting in possible bruising of the brain, tearing of nerve fibers and bleeding.
The medical term for a concussion is a mild traumatic brain injury (mTBI).
There is a growing need to personalize the return to play process based on the unique characteristics of both the injury and the athlete. For near term management, it is widely acknowledged that concussion susceptibility and response are highly individualized. Studies of former professional athletes also are confirming that certain individuals develop cognitive impairment after their career while others do not.
Athleticode is pioneering the development of technologies that provide physicians, certified athletic trainers and their athletes with information that optimizes the return to competition. Our technologies help physicians and certified athletic trainers develop and recommend appropriate return to play regimens for each athlete based on aspects of the athlete’s injury and response.
A new, comprehensive suite of concussion technologies providing a cutting edge approach to return to play
Utilizing advanced technologies, Athleticode samples and tests relevant genetic information of Apolipoprotein E, a gene that has been associated with different susceptibility and response to TBI. This information helps doctors make the most informed recommendations on an athlete’s return to play schedule.
Athleticode’s test results are reported within the context of publicly available scientific and medical literature and clinical trials covering the concussion field, integrating complex genomic research in a coordinated and easily accessible way for physicians to create return to play programs for each athlete on an individualized basis.
The Code is positioned for success
Athleticode was founded by world leaders in genome technology, traumatic brain injury research and professional sports.
- According to the CDC (Centers for Disease Control and Prevention), about one third of injury related American deaths are linked to TBI. About 230,000 hospitalizations occur annually in the US and about 1.1 million Americans are treated for TBI and released from an emergency department.
- Almost 2% of the US population lives with TBI-related disabilities and about 2 million American adults and children suffer from traumatic brain injury annually, with 50,000 individuals dying annually in America as a result of TBI.
- Every 15 seconds one American man, woman or child sustains a significant traumatic brain injury.
- The direct medical costs and indirect costs, such as lost productivity of TBI totaled an estimated $60 billion in the USA in 2000.
- In younger American’s the statistics are even worse. Among American children aged up to 14 years, TBI results in an estimated 2,685 deaths, 37,000 hospitalizations and 435,000 emergency department visits annually.
- There are over 300,000 TBIs per year suffered by high school athletes. 50% of high school athletes have problems returning from sport concussion. There is no medical therapy.